Home / Drug shortages / Haloperidol Decanoate Injection

Haloperidol Decanoate Injection — FDA Drug Shortage

To Be Discontinued — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Haloperidol Decanoate Injection (injection) from Fresenius Kabi USA, LLC with status To Be Discontinued. The shortage was first posted on 01/09/2026.

Shortage Details

Status
To Be Discontinued
Company
Fresenius Kabi USA, LLC
Package NDC
63323-469-05
Dosage Form
Injection
Presentation
Haloperidol Decanoate, Injection, 50 mg/1 mL (NDC 63323-469-05)
Initial Posting
01/09/2026
Revised Date

FDA data resources